Ignite Creation Date:
2024-05-06 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05877001
Status:
RECRUITING
Last Update Posted:
2023-05-26
First Post:
2023-01-17
Brief Title:
The Safety and Efficacy of HAICTislelizumabRegorafenib in Patients With Colorectal Liver Metastases
Sponsor:
Peking University Cancer Hospital Institute
Organization:
Peking University Cancer Hospital Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-17
First Submit QC Date:
May 25 2023
Study First Post Date:
2023-05-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-25
Last Update Post Date:
2023-05-26
Last Update Post Date Type:
ACTUAL